A review of the latest leadership moves in the pharma industry.
With ongoing technological advancements and the growing demand for improved healthcare solutions, digital therapeutics are poised to play an increasingly critical role in the future of medicine and digital health. However, achieving market access remains a major challenge due to regulatory and reimbursement complexities.
Agencies with healthcare clients in pharmaceuticals, healthcare services, digital health apps, or health-related connected devices such as wearables should take note that the Federal Trade Commission (FTC) final rule updating its Health Breach Notification Rule (HBNR) took effect on July 29, 2024.
Today’s serving of alphabet noodle soup to the biopharma industry – IRA, JCA, AAV, VC, and PM to list just five – may seem unpalatable, but the bigger picture is enticing. To focus disproportionately on the challenges is an understandable, tactical response, but we feel that the industry is on the cusp of a new era of growth and transformation, and that this should be celebrated.
Revita is an outpatient endoscopic procedure that involves resurfacing the mucosal lining of the duodenum, the first part of the small intestine just after the stomach, which is responsible for breaking down food into absorbable nutrients.
The combination therapy is one step closer to becoming a potential new first-line standard of care for patients with unresectable or metastatic urothelial carcinoma in Europe.
The Department of Health and Human Services’ Office of the Inspector General found that bluebird bio’s fertility support program for its gene therapies could potentially violate federal anti-kickback statutes.
Industry veteran Jay Carter is heading back into the industry by joining CG Life as executive VP, business strategy.
Joining as chief creative officer, Florence has “deep pharma and consumer chops.”
The deal is a major development coming on the heels of JPA’s acquisition of BioCentric, Inc. a clinical communications company based in greater Philadelphia and Switzerland (May 2024), and True North Solutions last fall, as well as the launch of GRETEL Trails, JPA’s proprietary AI-powered insight engine and chatbot, last summer.